Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation
- 1 March 2004
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 77 (3) , 932-941
- https://doi.org/10.1016/s0003-4975(03)01519-4
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activationThe Journal of Thoracic and Cardiovascular Surgery, 1999
- A Neoepitope‐Based Enzyme Immunoassay for Quantification of C1‐Inhibitor in Complex with C1r and C1sScandinavian Journal of Immunology, 1997
- Heparin in Clinical Doses ‘Primes’ Granulocytes to Subsequent Activation as Measured by Myeloperoxidase ReleaseScandinavian Journal of Immunology, 1996
- Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.Journal of Clinical Investigation, 1995
- A New Model for Evaluation of Biocompatibility: Combined Determination of Neoepitopes in Blood and on Artificial Surfaces Demonstrates Reduced Complement Activation by Immobilization of HeparinArtificial Organs, 1995
- Modification of the Complement Binding Properties of Polystyrene: Effects of End‐Point Heparin AttachmentScandinavian Journal of Immunology, 1993
- Plasma Levels of Main Granulocyte Components during HemodialysisAmerican Journal of Nephrology, 1990
- Quantification in Enzyme‐Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3Scandinavian Journal of Immunology, 1988
- An enzyme linked immunosorbent assay for measurements of lactoferrin in duodenal aspirates and other biological fluidsScandinavian Journal of Clinical and Laboratory Investigation, 1985
- Complement Metabolism During Membrane Plasma SeparationArtificial Organs, 1983